Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to collect data on tolerance and effects of early treatment
with oxytocin in children with Prader Willi Syndrome aged from 3 to 4 years and to compare
these infants with not treated age-matched infants with Prader Willi Syndrome.